Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagen is the primary structural protein in the extracellular matrix (ECM) of skin and most connective tissues, with types I and III being the main forms involved in tissue repair. After injury, fibroblasts secrete new collagen to replace damaged matrix, providing a scaffold for cell migration, re-epithelialization, neovascularization, and tissue remodeling. The proportions of collagen types change dynamically during healing, influencing tissue strength and function. Matrix metalloproteinases (MMPs) and other enzymes regulate collagen deposition and degradation; imbalances can result in either chronic wounds or pathological fibrosis/scarring. "Collagen matrix support for tissue repair" thus refers to the essential structural and functional roles of collagen ECM in orchestrating the processes of acute wound closure and tissue remodeling, rather than a discrete druggable target[2][3][4]. In summary, "Collagen matrix support for tissue repair" is a biological process and not a canonical molecular target. It refers to the collective role of collagens (mainly types I and III) and associated matrix remodeling proteins in tissue repair, rather than a single entity that can be structurally or pharmacologically targeted.
Drugs or devices may promote or enzymatically degrade the collagen matrix to enhance/remodel healing, or regulate cell migration and tissue regeneration[2][3].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen (types I and III).